Mayo Clinic is one of the premier treatment centers in the world for this rare cancer. It has cared for more than 100 patients with esthesioneuroblastoma, giving Mayo Clinic's experienced team of experts a greater understanding of this disease. A highly specialized team provides comprehensive, compassionate care to people with esthesioneuroblastoma.
Mayo Clinic Cancer Center is a leader in converting research knowledge to effective care of cancer patients and their families. Mayo Clinic diagnoses and treats all types of cancer for several thousand patients a year. That experience leads to providing the most effective treatment. The National Cancer Institute has designated Mayo Clinic Cancer Center as a comprehensive cancer center in recognition of its superior depth and breadth of research capabilities.
Mayo Clinic health care professionals understand the anxiety associated with cancer and work to give people the promptest diagnosis possible. Read more about diagnosis of esthesioneuroblastoma.
Mayo Clinic oncologists have treated virtually every kind of cancer, from the most common to the very rare. Treatment teams, working in state-of-the-art facilities, can diagnose the condition, reduce pain, and promote healing. Read more about treatment options for esthesioneuroblastoma.
Esthesioneuroblastoma (also called olfactory neuroblastoma) is a rare cancer of the upper part of the nasal cavity. It develops in nerve tissue associated with the sense of smell and can occur in people of any age. The cause is unknown. Although it generally grows slowly, an esthesioneuroblastoma can sometimes grow very quickly. Fast-growing tumors can metastasize (spread) even many years after treatment of the initial tumor. Recurrent or metastatic tumors can be difficult to treat successfully. When diagnosed in its early stages, esthesioneuroblastoma can often be treated successfully with surgery, radiation, and/or chemotherapy.